Can HCV core antigen replace HCV RNA testing in the era of direct-acting antivirals?
Van Tilborg, M, Almarzooqi, S, Maan, R, Vermehren, J, Maasoumy, B, Mazzulli, T, Kowgier, M, Janssen, H.L, De Knegt, R.J, Pawlotsky, J.-M, Cloherty, G, Sarrazin, C, Wedemeyer, H, Feld, J.J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Integrated analysis of controlled clinical trials evaluating efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C genotype 6 (HCV GT 6)
Nguyen, M.H, Chuang, W.-L, Hassanein, T, Kowdley, K, Lai, C.-L, Chan, H.L.-Y, Feld, J.J, Letterio, C, Hahambis, T.A, Llewellyn, J, De-Oertel, S, Brainard, D.M, Lawitz, E.J, Gane, E.J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
O116 HEPATITIS B SURFACE ANTIGEN (HBsAg) LEVELS DIFFER ACROSS HBV GENOTYPE AND PHENOTYPE: RESULTS FROM THE ADULT COHORT STUDY OF THE NIDDK-SPONSORED HEPATITIS B RESEARCH NETWORK
Brouwer, W.P, Cloonan, Y.K, Feld, J.J, Perrillo, R.P, Fried, M.W, Wong, D.K, Janssen, H.L.A
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P0735 : Assessment of baseline viral load cut-off for shortened ledipasvir/sofosbuvir therapy by widely used HCVRNA assays
Vermehren, J, Maasoumy, B, Chevaliez, S, Feld, J.J, Cloherty, G, Pawlotsky, J.-M, Sarrazin, C, Wedemeyer, H
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
LP39 : Implications of baseline HCVRNA level and intrapatient viral load variability on OBV/PTV/R + DSV 12-week treatment outcomes
Brown, R.S, Puoti, M, Cooper, C, Wyles, D.L, Sepe, T.E, Nahass, R.G, King, M, Coakley, E, McGovern, B.H, Feld, J.J
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
Safety of Direct-Acting Antivirals-Based Therapy for the Treatment of Patients with Chronic Hepatitis C Virus Infection and Cirrhosis: Results from an International Multicenter Cohort Study
Maan, R, van Tilborg, M, Deterding, K, Ramji, A, van der Meer, A.J, Wong, F, Fung, S, Sherman, M, Manns, M.P, Cornberg, M, Wedemeyer, H, Janssen, H.L, de Knegt, R.J, Feld, J.J
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance
Bartlett, S.R, Grebely, J, Eltahla, A.A, Reeves, J.D, Howe, A, Miller, V, Bull, R.A, Ceccherini-Silberstein, F, Douglas, M.W, Dore, G.J, Harrington, P, Lloyd, A.R, Jacka, B, Matthews, G.V, Wang, G.P, Pawlotsky, J.-M, Feld, J.J, Schinkel, J, Garcia, F, Lennerstrand, J, Applegate, T.L
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P194 THE RISK OF HEPATITIS B-RELATED HEPATOCELLULAR CARCINOMA (HCC) IS REDUCED WITH ANTIVIRAL THERAPY: EVIDENCE FROM 3 HCC PREDICTION MODELS
Abu-Amara, M, Cerecchi, O, Mahli, G, Sharma, S, Yim, C, Shah, H, Wong, D.K, Janssen, H.L.A, Feld, J.J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study
Grebely, J, Dalgard, O, Conway, B, Cunningham, E, Bruggmann, P, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Applegate, T.L, Swan, T, Byrne, J, Lacalamita, M, Dunlop, A.J, Bruneau, J, Hellard, M.E, Matthews, G.V, Powis, J, Shaw, D, Thurnheer, C.M, Weltman, M, Kronborg, I, Cooper, C, Feld, J.J, Fraser, C, Litwin, A, Dillon, J, Read, P, Gane, E, Dore, G.J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P1345 : A randomized, open-label study to evaluate efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis
Asselah, T, Hassanein, T, Qaqish, R.B, Feld, J.J, Hezode, C, Zeuzem, S, Ferenci, P, Pilot-Matias, T, Yu, Y, Mobashery, N
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
P0330 : Cost-effectiveness analysis of hepatocellular carcinoma surveillance in patients with hepatitis C related cirrhosis after sustained virological response
Farhang Zangneh, H, Wong, W.W, Sander, B, Bell, C.M, Mumtaz, K, Kowgier, M, Van Der Meer, A.J, Cleary, S.P, Chan, K, Feld, J.J
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
O60 SAPPHIRE I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAIVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1
Feld, J.J, Kowdley, K.V, Coakley, E, Sigal, S, Nelson, D, Crawford, D, Weiland, O, Aguilar, H, Xiong, J, DaSilva-Tillmann, B, Larsen, L, Podsadecki, T
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1220 MODELING PREDICTS CLINICALLY MEANINGFUL SVR RATES IN GENOTYPE 1 TREATMENT-EXPERIENCED PATIENTS BASED ON RESULTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS TREATED WITH SOFOSBUVIR + PEGINTERFERON + RIBAVIRIN FOR 12 WEEKS
Muir, A, Nelson, D.R, Gordon, S.C, Feld, J.J, Patel, K, Lawitz, E, Sheikh, A.M, Brainard, D.M, Symonds, W.T, McHutchison, J.G, Bekele, B.N, Mangia, A, Gane, E.J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1180 CAN A LIFESTYLE MODIFICATION INTERVENTION IMPROVE RISK FACTORS FOR A NEGATIVE RESPONSE TO PEGINTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND OBESITY?
Agarwal, A, Pattullo, V, Garcia-Saenz-de-Sicilia, M, Sockalingam, S, Fantus, I.G, Allard, J.P, Heathcote, E.J, Feld, J.J, Duarte-Rojo, A
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
P1176 INCIDENCE AND RISK FACTORS FOR INFECTIONS DURING INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Maan, R, van der Meer, A.J, Hansen, B.E, Feld, J.J, Wedemeyer, H, Dufour, J.-F, Zangneh, H.F, Lammert, F, Manns, M.P, Zeuzem, S, Janssen, H.L.A, de Knegt, R.J, Veldt, B.J
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
881 HIGH SVR RATES (SVR4) FOR 12-WEEK TOTAL TELAPREVIR COMBINATION THERAPY IN IL28B CC TREATMENT-NAÏVES AND PRIOR RELAPSERS WITH G1 CHRONIC HEPATITIS C: CONCISE INTERIM ANALYSIS
Nelson, D.R, Poordad, F, Feld, J.J, Fried, M.W, Jacobson, I.M, Pockros, P.J, Sulkowski, M.S, Zeuzem, S, Bengtsson, L, George, S, Friedman, M.I
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
504 IMPROVEMENT OF INTERFERON-BASED THERAPY SUBSTANTIALLY REDUCED THE NUMBER NEEDED TO TREAT TO PREVENT HCC AMONG HCV GENOTYPE 1 INFECTED CIRRHOTICS
van der Meer, A.J.P, Veldt, B.J, Feld, J.J, Wedemeyer, H, Dufour, J.-F, Lammert, F, Duarte-Rojo, A, Manns, M.P, Zeuzem, S, Hofmann, W.P, de Knegt, R.J, Hansen, B.E, Janssen, H.L.A
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
932 FACTORS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER FIBROSIS
van der Meer, A.J.P, Hansen, B.E, Feld, J.J, Wedemeyer, H, Dufour, J.-F, Lammert, F, Duarte-Rojo, A, Manns, M.P, Kuske, L, Zeuzem, S, Hofmann, W.P, de Knegt, R.J, Veldt, B.J, Janssen, H.L.A
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article